MENU
+Compare
TEVA
Stock ticker: NYSE
AS OF
Jun 3 closing price
Price
$17.19
Change
-$0.07 (-0.41%)
Capitalization
15.06B

TEVA Teva Pharmaceutical Industries Limited Forecast, Technical & Fundamental Analysis

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world... Show more

TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TEVA with price predictions
Jun 02, 2025

Aroon Indicator for TEVA shows an upward move is likely

TEVA's Aroon Indicator triggered a bullish signal on May 19, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 218 similar instances where the Aroon Indicator showed a similar pattern. In of the 218 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 02, 2025. You may want to consider a long position or call options on TEVA as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

TEVA moved above its 50-day moving average on April 29, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TEVA crossed bullishly above the 50-day moving average on May 06, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TEVA advanced for three days, in of 284 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for TEVA moved out of overbought territory on May 09, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator moved out of overbought territory. In of the 43 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 59 cases where TEVA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for TEVA turned negative on May 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TEVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TEVA broke above its upper Bollinger Band on May 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TEVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.077) is normal, around the industry mean (61.833). P/E Ratio (22.624) is within average values for comparable stocks, (89.614). Projected Growth (PEG Ratio) (1.594) is also within normal values, averaging (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.982) is also within normal values, averaging (19.131).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

TEVA is expected to report earnings to rise 23.08% to 63 cents per share on August 06

Teva Pharmaceutical Industries Limited TEVA Stock Earnings Reports
Q2'25
Est.
$0.64
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.06
The last earnings report on May 07 showed earnings per share of 51 cents, beating the estimate of 47 cents. With 9.81M shares outstanding, the current market capitalization sits at 15.06B.
A.I.Advisor
published Dividends

TEVA paid dividends on December 12, 2017

Teva Pharmaceutical Industries Limited TEVA Stock Dividends
А dividend of $0.09 per share was paid with a record date of December 12, 2017, and an ex-dividend date of November 27, 2017. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
124 Dvora HaNevi’a Street
Phone
+972 39148213
Employees
37851
Web
https://www.tevapharm.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
MDX.X0.0017000.000040
+2.40%
Mdex cryptocurrency
IOST.X0.0036210.000084
+2.38%
IOST cryptocurrency
AVAX.X21.149673-0.032425
-0.15%
Avalanche cryptocurrency
CLV.X0.025547-0.000063
-0.24%
CLV cryptocurrency
1INCH.X0.217103-0.001134
-0.52%
1inch Network cryptocurrency

TEVA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TEVA has been loosely correlated with AMRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if TEVA jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TEVA
1D Price
Change %
TEVA100%
-0.41%
AMRX - TEVA
38%
Loosely correlated
+0.40%
PCRX - TEVA
28%
Poorly correlated
+0.61%
VTRS - TEVA
28%
Poorly correlated
+0.23%
ELAN - TEVA
27%
Poorly correlated
+0.30%
BHC - TEVA
26%
Poorly correlated
+2.23%
More